Variant report
Variant | nsv366532 |
---|---|
Chromosome Location | chr7:147855334-147861703 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:147851361..147853923-chr7:147858125..147859807,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76501298 | chr7:147856214-147856215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535339252 | chr7:147856220-147856221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557848520 | chr7:147856305-147856306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549059992 | chr7:147856333-147856334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs578089350 | chr7:147856344-147856345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182370028 | chr7:147856376-147856377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34159361 | chr7:147856386-147856387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs74391954 | chr7:147856391-147856392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574193291 | chr7:147856397-147856398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541616020 | chr7:147856405-147856406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562572295 | chr7:147856448-147856449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184464549 | chr7:147856449-147856450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368117416 | chr7:147856464-147856465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533374102 | chr7:147856477-147856478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541351703 | chr7:147856521-147856522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563717841 | chr7:147856576-147856577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532812532 | chr7:147856579-147856580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188861313 | chr7:147856588-147856589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370960568 | chr7:147856621-147856622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374360583 | chr7:147856636-147856637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs55897101 | chr7:147856675-147856676 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs566293966 | chr7:147856686-147856687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567077643 | chr7:147856695-147856696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534983125 | chr7:147856735-147856736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370373137 | chr7:147856740-147856741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552096619 | chr7:147856752-147856753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181447080 | chr7:147856755-147856756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537403038 | chr7:147856785-147856786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557397650 | chr7:147856800-147856801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576686835 | chr7:147860809-147860810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545096802 | chr7:147860836-147860837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559770055 | chr7:147860839-147860840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6959769 | chr7:147860843-147860844 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs181286366 | chr7:147860907-147860908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572430843 | chr7:147860973-147860974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34762666 | chr7:147860998-147860999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs527900970 | chr7:147861017-147861018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541565242 | chr7:147861026-147861027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186087897 | chr7:147861066-147861067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189364915 | chr7:147861068-147861069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546029920 | chr7:147861083-147861084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562593724 | chr7:147861091-147861092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148285994 | chr7:147861095-147861096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547841147 | chr7:147861218-147861219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112297062 | chr7:147861243-147861244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs527376406 | chr7:147861246-147861247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542778529 | chr7:147861279-147861280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150365782 | chr7:147861324-147861325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs180755639 | chr7:147861348-147861349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539607018 | chr7:147861374-147861375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 20808228 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Heart disease | 21282601 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Lobular carcinoma | 20920651 | CNVD |
Long-qt syndrome | 20920651 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:147856200-147856800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
2 | chr7:147860800-147861600 | Enhancers | Fetal Heart | heart |